Chapter/Section Purchase

1 Study Coverage
1.1 Bevacizumab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Bevacizumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100mg
1.2.3 400mg
1.3 Market by Application
1.3.1 Global Bevacizumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Age-related macular degeneration (AMD)
1.3.3 Ovarian Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bevacizumab Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Bevacizumab Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Bevacizumab Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bevacizumab Injection Sales by Region
2.4.1 Global Bevacizumab Injection Sales by Region (2017-2022)
2.4.2 Global Sales Bevacizumab Injection by Region (2023-2028)
2.5 Global Bevacizumab Injection Revenue by Region
2.5.1 Global Bevacizumab Injection Revenue by Region (2017-2022)
2.5.2 Global Bevacizumab Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bevacizumab Injection Sales by Manufacturers
3.1.1 Global Top Bevacizumab Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Bevacizumab Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bevacizumab Injection in 2021
3.2 Global Bevacizumab Injection Revenue by Manufacturers
3.2.1 Global Bevacizumab Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Bevacizumab Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bevacizumab Injection Revenue in 2021
3.3 Global Bevacizumab Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bevacizumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bevacizumab Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bevacizumab Injection Sales by Type
4.1.1 Global Bevacizumab Injection Historical Sales by Type (2017-2022)
4.1.2 Global Bevacizumab Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Bevacizumab Injection Sales Market Share by Type (2017-2028)
4.2 Global Bevacizumab Injection Revenue by Type
4.2.1 Global Bevacizumab Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Bevacizumab Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bevacizumab Injection Revenue Market Share by Type (2017-2028)
4.3 Global Bevacizumab Injection Price by Type
4.3.1 Global Bevacizumab Injection Price by Type (2017-2022)
4.3.2 Global Bevacizumab Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bevacizumab Injection Sales by Application
5.1.1 Global Bevacizumab Injection Historical Sales by Application (2017-2022)
5.1.2 Global Bevacizumab Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Bevacizumab Injection Sales Market Share by Application (2017-2028)
5.2 Global Bevacizumab Injection Revenue by Application
5.2.1 Global Bevacizumab Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Bevacizumab Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bevacizumab Injection Revenue Market Share by Application (2017-2028)
5.3 Global Bevacizumab Injection Price by Application
5.3.1 Global Bevacizumab Injection Price by Application (2017-2022)
5.3.2 Global Bevacizumab Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bevacizumab Injection Market Size by Type
6.1.1 North America Bevacizumab Injection Sales by Type (2017-2028)
6.1.2 North America Bevacizumab Injection Revenue by Type (2017-2028)
6.2 North America Bevacizumab Injection Market Size by Application
6.2.1 North America Bevacizumab Injection Sales by Application (2017-2028)
6.2.2 North America Bevacizumab Injection Revenue by Application (2017-2028)
6.3 North America Bevacizumab Injection Market Size by Country
6.3.1 North America Bevacizumab Injection Sales by Country (2017-2028)
6.3.2 North America Bevacizumab Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bevacizumab Injection Market Size by Type
7.1.1 Europe Bevacizumab Injection Sales by Type (2017-2028)
7.1.2 Europe Bevacizumab Injection Revenue by Type (2017-2028)
7.2 Europe Bevacizumab Injection Market Size by Application
7.2.1 Europe Bevacizumab Injection Sales by Application (2017-2028)
7.2.2 Europe Bevacizumab Injection Revenue by Application (2017-2028)
7.3 Europe Bevacizumab Injection Market Size by Country
7.3.1 Europe Bevacizumab Injection Sales by Country (2017-2028)
7.3.2 Europe Bevacizumab Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bevacizumab Injection Market Size by Type
8.1.1 Asia Pacific Bevacizumab Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Bevacizumab Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Bevacizumab Injection Market Size by Application
8.2.1 Asia Pacific Bevacizumab Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Bevacizumab Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Bevacizumab Injection Market Size by Region
8.3.1 Asia Pacific Bevacizumab Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Bevacizumab Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bevacizumab Injection Market Size by Type
9.1.1 Latin America Bevacizumab Injection Sales by Type (2017-2028)
9.1.2 Latin America Bevacizumab Injection Revenue by Type (2017-2028)
9.2 Latin America Bevacizumab Injection Market Size by Application
9.2.1 Latin America Bevacizumab Injection Sales by Application (2017-2028)
9.2.2 Latin America Bevacizumab Injection Revenue by Application (2017-2028)
9.3 Latin America Bevacizumab Injection Market Size by Country
9.3.1 Latin America Bevacizumab Injection Sales by Country (2017-2028)
9.3.2 Latin America Bevacizumab Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bevacizumab Injection Market Size by Type
10.1.1 Middle East and Africa Bevacizumab Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bevacizumab Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Bevacizumab Injection Market Size by Application
10.2.1 Middle East and Africa Bevacizumab Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bevacizumab Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Bevacizumab Injection Market Size by Country
10.3.1 Middle East and Africa Bevacizumab Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bevacizumab Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Genentech
11.4.1 Genentech Corporation Information
11.4.2 Genentech Overview
11.4.3 Genentech Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genentech Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genentech Recent Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Overview
11.5.3 Bayer Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Recent Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Amgen Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Recent Developments
11.7 Samsung Bioepis
11.7.1 Samsung Bioepis Corporation Information
11.7.2 Samsung Bioepis Overview
11.7.3 Samsung Bioepis Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Samsung Bioepis Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Samsung Bioepis Recent Developments
11.8 Centus
11.8.1 Centus Corporation Information
11.8.2 Centus Overview
11.8.3 Centus Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Centus Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Centus Recent Developments
11.9 Cadila Pharmaceuticals
11.9.1 Cadila Pharmaceuticals Corporation Information
11.9.2 Cadila Pharmaceuticals Overview
11.9.3 Cadila Pharmaceuticals Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cadila Pharmaceuticals Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cadila Pharmaceuticals Recent Developments
11.10 Dr Reddy's
11.10.1 Dr Reddy's Corporation Information
11.10.2 Dr Reddy's Overview
11.10.3 Dr Reddy's Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Dr Reddy's Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dr Reddy's Recent Developments
11.11 Mylan
11.11.1 Mylan Corporation Information
11.11.2 Mylan Overview
11.11.3 Mylan Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Mylan Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mylan Recent Developments
11.12 Hetero Group
11.12.1 Hetero Group Corporation Information
11.12.2 Hetero Group Overview
11.12.3 Hetero Group Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hetero Group Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hetero Group Recent Developments
11.13 Biocon
11.13.1 Biocon Corporation Information
11.13.2 Biocon Overview
11.13.3 Biocon Bevacizumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Biocon Bevacizumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Biocon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bevacizumab Injection Industry Chain Analysis
12.2 Bevacizumab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bevacizumab Injection Production Mode & Process
12.4 Bevacizumab Injection Sales and Marketing
12.4.1 Bevacizumab Injection Sales Channels
12.4.2 Bevacizumab Injection Distributors
12.5 Bevacizumab Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bevacizumab Injection Industry Trends
13.2 Bevacizumab Injection Market Drivers
13.3 Bevacizumab Injection Market Challenges
13.4 Bevacizumab Injection Market Restraints
14 Key Findings in The Global Bevacizumab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer